<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051670</url>
  </required_header>
  <id_info>
    <org_study_id>4-2021-0881</org_study_id>
    <nct_id>NCT05051670</nct_id>
  </id_info>
  <brief_title>da Vinci SP Robotic Gastrectomy</brief_title>
  <official_title>The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using da Vinci SP for Early Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic surgery revolutionized the surgical treatment of gastric cancer saving large&#xD;
      incsion and associated pain. Robotic surgical system was introduced to enhance the minimally&#xD;
      invasive surgery using articulating robotic arm. The da vinci SP system, which enables&#xD;
      single-port surgery, can allow surgeon to provide radical gastrectomy with minimal scar and&#xD;
      associated pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a phase 1/2, single-arm surgical clinical trial. The primary endpoint is the&#xD;
      safety of da vinci robotic gastrectomy. The secondary endpoint is operative time, bleeding,&#xD;
      bowel recovery, and hospital stay. In the clinic, informed consent is received from patient&#xD;
      who is scheduled to undergo radical gastrectomy. After the general anesthesia, low midline&#xD;
      transverse incision is made at suprapubic area. After inserting SP port into the peritoneal&#xD;
      cavity, additional port is inserted via right flank that would be used for assistant's energy&#xD;
      device and suction devices. Radical subtotal gastrectomy is perfromed using cardiere-forceps,&#xD;
      monopolar scissors, and maryland forceps. Reconstruction after gastrectomy is decided&#xD;
      according to surgeon's preference. three days after gastrectomy, if the diet build up is&#xD;
      complete and the patients has no evidence of complication, the patient is discharged from the&#xD;
      hospital. Four weeks after gastrectomy, the patient will be followed up at the clinic. Major&#xD;
      complication event within 30days after gastrectomy will be analyzed as primary endpoint as&#xD;
      well as other secondary endpoints.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">August 16, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>major complication</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>Clavien-Dindo classification grade 3 or more</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>duation of operation in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bleeding</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>amount of bleeding shed during the operation in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bowel recovery</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>gas passing day after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>days between the opeation day to discharge day</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">19</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>SP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients group underwent gastrectomy using da vinci SP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>da vinc SP gastrectomy</intervention_name>
    <description>radical subtotal gastrectomy performed by da vinci SP</description>
    <arm_group_label>SP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Biopsy confirmed adenocarcinoma of stomach scheduled to undergo radical gastrectomy&#xD;
&#xD;
          -  Between 20-80&#xD;
&#xD;
          -  ASA score (American society of anesthesiology) class: I - III&#xD;
&#xD;
          -  Signed to informed consent after through explanation about the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  distant metastasis&#xD;
&#xD;
          -  EMR/ESD canddiate&#xD;
&#xD;
          -  complicated gastric cancer (obstruction or perforation)&#xD;
&#xD;
          -  Active other primary tumor&#xD;
&#xD;
          -  Vulerable subject (illiterate, pregnant)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hyoung-Il Kim</last_name>
    <phone>82-2-2228-2100</phone>
    <email>cairus@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Hyoung-Il Kim</last_name>
      <phone>82-2-2228-2100</phone>
      <email>cairus@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011 Jun;11(2):69-77. doi: 10.5230/jgc.2011.11.2.69. Epub 2011 Jun 30.</citation>
    <PMID>22076206</PMID>
  </reference>
  <reference>
    <citation>Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J. 2012 Mar;53(2):248-57. doi: 10.3349/ymj.2012.53.2.248. Review.</citation>
    <PMID>22318810</PMID>
  </reference>
  <reference>
    <citation>Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994 Apr;4(2):146-8. Erratum in: Surg Laparosc Endosc. 2013 Oct;23(5):480.</citation>
    <PMID>8180768</PMID>
  </reference>
  <reference>
    <citation>Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010 Mar;251(3):417-20. doi: 10.1097/SLA.0b013e3181cc8f6b.</citation>
    <PMID>20160637</PMID>
  </reference>
  <reference>
    <citation>Zeng YK, Yang ZL, Peng JS, Lin HS, Cai L. Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: evidence from randomized and nonrandomized clinical trials. Ann Surg. 2012 Jul;256(1):39-52. doi: 10.1097/SLA.0b013e3182583e2e. Review.</citation>
    <PMID>22664559</PMID>
  </reference>
  <reference>
    <citation>Kim YM, Baek SE, Lim JS, Hyung WJ. Clinical application of image-enhanced minimally invasive robotic surgery for gastric cancer: a prospective observational study. J Gastrointest Surg. 2013 Feb;17(2):304-12. doi: 10.1007/s11605-012-2094-0. Epub 2012 Dec 1.</citation>
    <PMID>23207683</PMID>
  </reference>
  <reference>
    <citation>Cruz CJ, Huynh F, Kang I, Lee WJ, Kang CM. Initial experiences of robotic SP cholecystectomy: a comparative analysis with robotic Si single-site cholecystectomy. Ann Surg Treat Res. 2021 Jan;100(1):1-7. doi: 10.4174/astr.2021.100.1.1. Epub 2020 Dec 30.</citation>
    <PMID>33457391</PMID>
  </reference>
  <reference>
    <citation>Kang SK, Jang WS, Kim SW, Kim SH, Han SW, Lee YS. Robot-assisted laparoscopic single-port pyeloplasty using the da Vinci SPÂ® system: initial experience with a pediatric patient. J Pediatr Urol. 2019 Oct;15(5):576-577. doi: 10.1016/j.jpurol.2019.08.003. Epub 2019 Aug 15.</citation>
    <PMID>31570233</PMID>
  </reference>
  <reference>
    <citation>Gomes MTV, Machado AMN, Podgaec S, Barison GAS. Initial experience with single-port robotic hysterectomy. Einstein (Sao Paulo). 2017 Oct-Dec;15(4):476-480. doi: 10.1590/S1679-45082017AO4134. English, Portuguese.</citation>
    <PMID>29364368</PMID>
  </reference>
  <reference>
    <citation>Tokunaga M, Sugisawa N, Kondo J, Tanizawa Y, Bando E, Kawamura T, Terashima M. Early phase II study of robot-assisted distal gastrectomy with nodal dissection for clinical stage IA gastric cancer. Gastric Cancer. 2014;17(3):542-7. doi: 10.1007/s10120-013-0293-3. Epub 2013 Sep 5.</citation>
    <PMID>24005955</PMID>
  </reference>
  <reference>
    <citation>Lee S, Kim JK, Kim YN, Jang DS, Kim YM, Son T, Hyung WJ, Kim HI. Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial. Surg Endosc. 2017 Oct;31(10):4002-4009. doi: 10.1007/s00464-017-5435-y. Epub 2017 Feb 15.</citation>
    <PMID>28205030</PMID>
  </reference>
  <reference>
    <citation>Park JY, Jo MJ, Nam BH, Kim Y, Eom BW, Yoon HM, Ryu KW, Kim YW, Lee JH. Surgical stress after robot-assisted distal gastrectomy and its economic implications. Br J Surg. 2012 Nov;99(11):1554-61. doi: 10.1002/bjs.8887.</citation>
    <PMID>23027072</PMID>
  </reference>
  <reference>
    <citation>Kim HH, Han SU, Kim MC, Hyung WJ, Kim W, Lee HJ, Ryu SW, Cho GS, Song KY, Ryu SY. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol. 2014 Mar 1;32(7):627-33. doi: 10.1200/JCO.2013.48.8551. Epub 2014 Jan 27.</citation>
    <PMID>24470012</PMID>
  </reference>
  <reference>
    <citation>Tokunaga M, Kondo J, Tanizawa Y, Bando E, Kawamura T, Terashima M. Postoperative intra-abdominal complications assessed by the Clavien-Dindo classification following open and laparoscopy-assisted distal gastrectomy for early gastric cancer. J Gastrointest Surg. 2012 Oct;16(10):1854-9. Epub 2012 Jul 31.</citation>
    <PMID>22847575</PMID>
  </reference>
  <reference>
    <citation>Kim SM, Ha MH, Seo JE, Kim JE, Choi MG, Sohn TS, Bae JM, Kim S, Lee JH. Comparison of Reduced Port Totally Laparoscopic Distal Gastrectomy (Duet TLDG) and Conventional Laparoscopic-Assisted Distal Gastrectomy. Ann Surg Oncol. 2015 Aug;22(8):2567-72. doi: 10.1245/s10434-014-4333-y. Epub 2015 Jan 7.</citation>
    <PMID>25564174</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>da vinci SP</keyword>
  <keyword>robotic surgery</keyword>
  <keyword>gastrectomy</keyword>
  <keyword>gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

